Art Mercurio has been awarded two new NCI R01 grants: “VEGF Signaling in Mammary Tumorigenesis” and “Mechanisms of Carcinoma Differentiation and Invasion”. He also received a grant from the DOD Prostate Cancer Program “Neuropilin-2: A Novel Biomarker and Therapeutic Target for Aggressive Prostate Cancer”.